SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions, today announced financial results for the Company's fiscal first quarter ended December 31, 2020.
Fiscal First Quarter 2021 Financial Summary
Fiscal 2021 first quarter revenues were $8.0 million, down from $8.8 million in the prior year quarter due to the delayed shipment of an order because the customer-required payment was not received prior to the quarter end. The payment was subsequently received and the order shipped in early January.
Gross profit margin was 46.1%, compared with 52.4% in the first quarter of fiscal 2020. The decrease was attributable to lower revenues, an 86% increase in software engineering personnel over last year and additional engineering charges resulting from a more precise process to charge engineering expenses to cost of sales.
Operating expenses were $4.4 million, an increase of 13% from $3.9 million in the same period a year ago. The increase was largely due to higher selling, general and administrative expenses from a 50% increase in sales and marketing personnel over the prior year period to support future revenue growth opportunities.
Net loss for the quarter was $0.6 million, or $(0.02) per share, compared with net income of $0.6 million, or $0.02 per share, in the first quarter of fiscal 2020. The decrease was due primarily to lower revenue and increased engineering, sales and marketing expenses.
Cash, cash equivalents and marketable securities totaled $27.5 million on December 31, 2020, compared with $31.4 million on September 30, 2020. The decrease was principally due to the acquisition of Amika Mobile, partially offset by $1.3 million generated in operating cash.
Working capital totaled $25.6 million on December 31, 2020, compared with $29.8 million on September 30, 2020.
"Record fiscal first quarter bookings of $12.2 million were 43% higher than the first six months of fiscal 2020," said Richard S. Danforth, Chief Executive Officer of Genasys Inc. "Strong bookings and backlog are expected in the fiscal second quarter that will help propel the Company to another year of record revenues."
Select Fiscal First Quarter 2021 Operating and Business Highlights
- Closed acquisition of Amika Mobile and rebranded company as Genasys Communications Canada
- Announced $7.7 million in U.S. defense orders
- Awarded U.S. Navy SBIR program research and development project
- Received $1.6 million in international law enforcement, homeland security and mass notifications orders
- Recognized in Gartner 2020 Market Guide for Emergency/Mass Notification Services Solutions
"The technology and personnel investments we're making in our software business are significantly increasing emergency management, enterprise safety and mobile mass messaging sales opportunities," continued Mr. Danforth. "Our multi-year contract awards in Australia and the many recent and expected requests for proposal from the European Union initiative, and from North America for our enterprise solutions, have us well-positioned for record fiscal year software bookings and revenue."
"Several integrated public safety mass notification systems contracts, as well as a large U.S. Army LRAD® 450XL program order are also anticipated this fiscal year," Mr. Danforth concluded. "With record fiscal first quarter bookings totaling $3.7 million more than the first six months of fiscal 2020 and strong bookings and backlog growth expected in our fiscal second quarter, Genasys is on pace for another year of record revenues."
We include in this press release Non-GAAP operational metrics of bookings, which we believe provide helpful information to investors with respect to evaluating the Company's performance. We consider bookings as leading indicators of future revenues and use these metrics to support production planning. Bookings is an internal, operational metric that measures the total dollar value of customer purchase orders executed in a period, regardless of the timing of the related revenue recognition.
Webcast and Conference Call Details
Management will host a conference call to discuss the fiscal first quarter 2021 financial results this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (404) 267-0369. A webcast will also be available at the following link: https://www.webcaster4.com/Webcast/Page/1375/39912
Questions to management may be submitted before the call by emailing them to: ir@genasys.com. A replay of the webcast will be available approximately four hours after the presentation on the Events & Presentations page of the Company's website.
About Genasys Inc.
Genasys™ is a global provider of critical communications systems and solutions to help keep people safe. Genasys provides a multi-channel approach to deliver geo-targeted alerts, notifications, instructions and information before, during and after public safety threats and critical business events. The Company's unified critical communications platform includes Genasys Emergency Management (GEM) applications, National Emergency Warning Systems (NEWS), LRAD® long-range voice broadcast systems, and more.
Genasys systems are in service in 72 countries and in more than 450 U.S. cities in a range of diverse applications, including public safety, emergency warning, mass notification, critical event management, defense, law enforcement, homeland security, and many more. For more information, visit genasys.com.
Forward-Looking Statements
Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties, including without limitation the business impact of health crises or outbreaks of disease, such as epidemics or pandemics, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the "Risk Factors" section of the Company's Form 10-K for the fiscal year ended September 30, 2020. Genasys Inc. disclaims any intent or obligation to update those forward-looking statements, except as otherwise specifically stated.
Investor Relations Contacts
Jim Fanucchi and Satya Chillara
Darrow Associates, Inc.
ir@genasys.com
| Genasys Inc. | ||||||||
| Condensed Consolidated Balance Sheets | ||||||||
| (Unaudited - in thousands) | ||||||||
| December 31, | ||||||||
| 2020 | September 30, | |||||||
| (unaudited) | 2019 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 19,584 | $ | 23,319 | ||||
| Short-term marketable securities | 5,517 | 4,265 | ||||||
| Restricted cash | 295 | 282 | ||||||
| Accounts receivable, net | 3,159 | 5,442 | ||||||
| Inventories, net | 6,963 | 5,949 | ||||||
| Prepaid expenses and other | 713 | 860 | ||||||
| Total current assets | 36,231 | 40,117 | ||||||
| Long-term marketable securities | 2,419 | 3,805 | ||||||
| Long-term restricted cash | 1,180 | 395 | ||||||
| Deferred tax assets, net | 11,100 | 11,095 | ||||||
| Property and equipment, net | 1,885 | 1,930 | ||||||
| Goodwill | 8,500 | 2,472 | ||||||
| Intangible assets, net | 3,743 | 943 | ||||||
| Operating lease right of use asset | 5,384 | 5,285 | ||||||
| Prepaid expenses and other - noncurrent | 161 | 125 | ||||||
| Total assets | $ | 70,603 | $ | 66,167 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 1,618 | $ | 1,370 | ||||
| Accrued liabilities | 7,848 | 7,880 | ||||||
| Notes payable, current portion | 314 | 300 | ||||||
| Operating lease liabilities, current portion | 848 | 771 | ||||||
| Total current liabilities | 10,628 | 10,321 | ||||||
| Notes payable, less current portion | 18 | 18 | ||||||
| Other liabilities, noncurrent | 915 | 293 | ||||||
| Operating lease liabilities, noncurrent | 6,385 | 6,395 | ||||||
| Total liabilities | 17,946 | 17,027 | ||||||
| Total stockholders' equity | 52,657 | 49,140 | ||||||
| Total liabilities and stockholders' equity | $ | 70,603 | $ | 66,167 | ||||
| Genasys Inc. | |||||||
| Condensed Consolidated Statements of Operations | |||||||
| (Unaudited - in thousands, except per share amounts) | |||||||
| Three months ended | |||||||
| December 31, | |||||||
| 2020 | 2019 | ||||||
| (unaudited) | (unaudited) | ||||||
| Revenues | $ | 8,028 | $ | 8,782 | |||
| Cost of revenues | 4,324 | 4,180 | |||||
| Gross profit | 3,704 | 4,602 | |||||
| Operating expenses: | |||||||
| Selling, general and administrative | 3,331 | 2,822 | |||||
| Research and development | 1,066 | 1,084 | |||||
| Total operating expenses | 4,397 | 3,906 | |||||
| (Loss) income from operations | (693 | ) | 696 | ||||
| Other income and expense, net | 69 | 96 | |||||
| (Loss) income before income taxes | (624 | ) | 792 | ||||
| Income tax (benefit) expense | (5 | ) | 172 | ||||
| Net (loss) income | $ | (619 | ) | $ | 620 | ||
| Net (loss) income per common share: | |||||||
| Basic | $ | (0.02 | ) | $ | 0.02 | ||
| Diluted | $ | (0.02 | ) | $ | 0.02 | ||
| Weighted average common shares outstanding: | |||||||
| Basic | 33,574 | 32,978 | |||||
| Diluted | 33,574 | 33,711 | |||||
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
